Earth Science Tech Inc. (ETST) Innovating as World
Post# of 333
(Total Views: 603)
Posted On: 07/09/2019 5:35:00 PM
Earth Science Tech Inc. (ETST) Innovating as Worldwide Leader in CBD Space
- Earth Science Tech markets high quality, full-spectrum hemp CBD oil
- The company’s subsidiaries focus on developing roles as international leaders in the CBD arena
- ETST has various partnerships in place to foster product innovation
Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices and research and development. Headquartered in Doral, Florida, the company offers CBD in the form of vitamins, minerals, herbs, botanicals, personal-care products, homeopathies, functional foods and other products. An inventive biotech enterprise, ETST provides high purity and quality full-spectrum hemp CBD oil to the booming CBD market.
The company’s wholly owned subsidiaries focus on developing ETST’s role as a global leader in the CBD space. The subsidiaries also focus on expanding Earth Science Tech’s work in the pharmaceutical and medical device sectors. Earth Science Tech’s business approach includes promoting its varied portfolio and pipeline while also engaging in strategic partnerships.
ETST has partnered with the University of Central Oklahoma and DV Biologics Laboratory to work on projects that scientifically support and advance the health care benefits of its high-grade hemp CBD oil. Earth Science Tech’s CBD oil is 100 percent natural and organic and is manufactured using a supercritical CO2 liquid extraction process.
Earth Science Tech has agreements with CannaBiz and Desert Sun Distribution (http://nnw.fm/Q0zqC). These agreements are part of a wider strategy implemented by ETST Chief Sales Officer David Burbash, who is expanding the sales team to explore product placement in large chains, health food stores and other establishments. These agreements are for the distribution of a high-grade, full-spectrum cannabinoids line throughout pharmacies, chiropractors, dispensaries, athletic clubs and clinics in the United States.
“We see tremendous synergy between our CBD line and the health care practitioner and pharmacy spaces,” Burbash stated in a news release. “The distribution agreements with CannaBiz and Desert Sun Distribution, while important, are only a fraction of the opportunities we see for our CBD products.”
ETST’s Earth Science Pharmaceutical Inc. subsidiary is developing and pioneering medical devices and vaccines to improve women’s health around the world (http://nnw.fm/46AmT). The company is developing low-cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases (STIs). Its first medical device is MSN-2, a home kit designed for the detection of STIs such as chlamydia from a self-obtained gynecological specimen. The company is advancing clinical trials of MSN-2 via a collaborative agreement with Laboratories BNK Canada.
The company’s Cannabis Therapeutics Inc. subsidiary is a biotech firm focusing on CBD research and development for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions (http://nnw.fm/rW2W5). The company is working to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics has a provisional application patent for CBD, and its first projects are centered on developing treatments for breast and ovarian cancers.
Earth Science Tech also has its Canna Inno Laboratories Inc. subsidiary. The acquisition of Canna Inno provides the company with access to Government of Canada funding, the first of which has received approval (http://nnw.fm/XwB8e). Headquartered in Montreal, Canna Inno Laboratories gives Earth Science Tech a presence in the province of Quebec.
Earth Science Tech continues to advance its product development in varied dynamic sectors. The company offers investors the potential for return on investment through its CBD products and international provisional patent applications. Earth Science Tech is also advancing its vision by exploring opportunities in new medical frontiers with the unique integration of CBD with generic drug molecules.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Earth Science Tech markets high quality, full-spectrum hemp CBD oil
- The company’s subsidiaries focus on developing roles as international leaders in the CBD arena
- ETST has various partnerships in place to foster product innovation
Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices and research and development. Headquartered in Doral, Florida, the company offers CBD in the form of vitamins, minerals, herbs, botanicals, personal-care products, homeopathies, functional foods and other products. An inventive biotech enterprise, ETST provides high purity and quality full-spectrum hemp CBD oil to the booming CBD market.
The company’s wholly owned subsidiaries focus on developing ETST’s role as a global leader in the CBD space. The subsidiaries also focus on expanding Earth Science Tech’s work in the pharmaceutical and medical device sectors. Earth Science Tech’s business approach includes promoting its varied portfolio and pipeline while also engaging in strategic partnerships.
ETST has partnered with the University of Central Oklahoma and DV Biologics Laboratory to work on projects that scientifically support and advance the health care benefits of its high-grade hemp CBD oil. Earth Science Tech’s CBD oil is 100 percent natural and organic and is manufactured using a supercritical CO2 liquid extraction process.
Earth Science Tech has agreements with CannaBiz and Desert Sun Distribution (http://nnw.fm/Q0zqC). These agreements are part of a wider strategy implemented by ETST Chief Sales Officer David Burbash, who is expanding the sales team to explore product placement in large chains, health food stores and other establishments. These agreements are for the distribution of a high-grade, full-spectrum cannabinoids line throughout pharmacies, chiropractors, dispensaries, athletic clubs and clinics in the United States.
“We see tremendous synergy between our CBD line and the health care practitioner and pharmacy spaces,” Burbash stated in a news release. “The distribution agreements with CannaBiz and Desert Sun Distribution, while important, are only a fraction of the opportunities we see for our CBD products.”
ETST’s Earth Science Pharmaceutical Inc. subsidiary is developing and pioneering medical devices and vaccines to improve women’s health around the world (http://nnw.fm/46AmT). The company is developing low-cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases (STIs). Its first medical device is MSN-2, a home kit designed for the detection of STIs such as chlamydia from a self-obtained gynecological specimen. The company is advancing clinical trials of MSN-2 via a collaborative agreement with Laboratories BNK Canada.
The company’s Cannabis Therapeutics Inc. subsidiary is a biotech firm focusing on CBD research and development for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions (http://nnw.fm/rW2W5). The company is working to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics has a provisional application patent for CBD, and its first projects are centered on developing treatments for breast and ovarian cancers.
Earth Science Tech also has its Canna Inno Laboratories Inc. subsidiary. The acquisition of Canna Inno provides the company with access to Government of Canada funding, the first of which has received approval (http://nnw.fm/XwB8e). Headquartered in Montreal, Canna Inno Laboratories gives Earth Science Tech a presence in the province of Quebec.
Earth Science Tech continues to advance its product development in varied dynamic sectors. The company offers investors the potential for return on investment through its CBD products and international provisional patent applications. Earth Science Tech is also advancing its vision by exploring opportunities in new medical frontiers with the unique integration of CBD with generic drug molecules.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)